Condition: Hematologic Neoplasms · Sponsor: Ottawa Hospital Research Institute
It is hypothesized that a strategy using prophylactic oral and intravenous Tranexamic Acid (TXA) with therapeutic platelet transfusions (if required) is safe and more effective than prophylactic platelet transfusions in patients undergoing an autologous hematopoietic stem cell transplantation (ASCT).
This description comes directly from the study's public registry record.
Sohail Robert, RN · 613-737-8899 · sorobert@ohri.ca
Alan Tinmouth, MD · 613-737-8899 · atinmouth@ohri.ca
Always discuss trial participation with your own doctor first.
| Tom Baker Cancer Centre | Calgary, Alberta, Canada | Recruiting |
| Cross Cancer Institute | Edmonton, Alberta, Canada | Recruiting |
| Eastern Regional Health Authority | St. John's, Newfoundland and Labrador, Canada | Recruiting |
| Memorial University | St. John's, Newfoundland and Labrador, Canada | Not Yet Recruiting |
| Dalhousie University | Halifax, Nova Scotia, Canada | Not Yet Recruiting |
| Hamilton Health Sciences - Juravinski Hospital and Cancer Centre | Hamilton, Ontario, Canada | Recruiting |
| London Health Sciences Centre | London, Ontario, Canada | Recruiting |
| The Ottawa Hospital | Ottawa, Ontario, Canada | Recruiting |
| Niagara Health System | St. Catharines, Ontario, Canada | Recruiting |
| Princess Margaret Cancer Centre | Toronto, Ontario, Canada | Withdrawn |
| Hopital Maisonneuve-Rosemont | Montreal, Quebec, Canada | Not Yet Recruiting |
| Saskatchewan Cancer Agency | Saskatoon, Saskatchewan, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04448184